HQ - Cambridge
Summary
Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.
Deals Overview
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Barry Greene
CEO
Ashley Kaplowitz
Vice President, Investor Relations & Capital Markets
Mike Cloonan
COO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy